BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35074934)

  • 1. Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.
    Nezam D; Porcher R; Grolleau F; Morel P; Titeca-Beauport D; Faguer S; Karras A; Solignac J; Jourde-Chiche N; Maurier F; Sakhi H; El Karoui K; Mesbah R; Carron PL; Audard V; Ducloux D; Paule R; Augusto JF; Aniort J; Tiple A; Rafat C; Beaudreuil S; Puéchal X; Gobert P; Massy Z; Hanrotel C; Bally S; Martis N; Durel CA; Desbuissons G; Godmer P; Hummel A; Perrin F; Néel A; De Moreuil C; Goulenok T; Guerrot D; Grange S; Foucher A; Deroux A; Cordonnier C; Guilbeau-Frugier C; Modesto-Segonds A; Nochy D; Daniel L; Moktefi A; Rabant M; Guillevin L; Régent A; Terrier B;
    J Am Soc Nephrol; 2022 Mar; 33(3):628-637. PubMed ID: 35074934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides.
    Hakroush S; Korsten P; Ströbel P; Tampe B
    Front Immunol; 2024; 15():1340999. PubMed ID: 38380320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
    Toyoda T; Yates M; Watts RA
    Curr Rheumatol Rep; 2022 Apr; 24(4):111-117. PubMed ID: 35316496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.
    de Luna G; Chauveau D; Aniort J; Carron PL; Gobert P; Karras A; Marchand-Adam S; Maurier F; Hatron PY; Mania A; le Guenno G; Bally S; Bienvenu B; Cardineau E; Goulenok T; Jourde-Chiche N; Samson M; Huart A; Pourrat J; Tiple A; Aumaitre O; Puéchal X; Heshmati F; le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    J Autoimmun; 2015 Dec; 65():49-55. PubMed ID: 26330347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS).
    Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M;
    Am J Respir Crit Care Med; 2024 May; 209(9):1141-1151. PubMed ID: 38346237
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis.
    Bellos I; Michelakis I; Nikolopoulos D
    Clin Rheumatol; 2021 Apr; 40(4):1447-1456. PubMed ID: 32935248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
    Park PG; Yoo BW; Song JJ; Park YB; Lee SW
    BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange for the management of ANCA-associated vasculitis: the con position.
    Specks U; Fussner LA; Cartin-Ceba R; Casal Moura M; Zand L; Fervenza FC
    Nephrol Dial Transplant; 2021 Jan; 36(2):231-236. PubMed ID: 33374017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Histopathology in ANCA-Associated Vasculitides Treated with Plasma Exchange.
    Casal Moura M; Soler MJ; Sethi S; Fervenza FC; Specks U
    J Am Soc Nephrol; 2022 Jun; 33(6):1223-1224. PubMed ID: 35410878
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in ANCA-associated vasculitis: the pro position.
    Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
    Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.
    Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR;
    Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic effect of plasma exchange on ANCA-associated vasculitis: A meta-analysis.
    Zhu Y; Rao J; Liu L; Ou J; Li W; Xue C
    Clin Nephrol; 2021 Jun; 95(6):312-322. PubMed ID: 33749583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange in patients with ANCA-associated vasculitis.
    Chalkia A; Petras D
    Transfus Apher Sci; 2024 Feb; 63(1):103847. PubMed ID: 38008685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis.
    Kristensen T; Gregersen JW; Krag SR; Ivarsen P
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S105-10. PubMed ID: 27241586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late effects of therapeutic plasma exchange in patients with systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: A single-center experience.
    Al Hamzi HA; Al-Mayouf SM; Al Shaikh AA; Al-Sheikh HA; Alshomar AA; Al Humaidan HA; Al Dalaan AN; Al Saleh SS
    Saudi J Kidney Dis Transpl; 2019; 30(4):775-780. PubMed ID: 31464233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis--a 25-year perspective.
    Szpirt WM
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i146-9. PubMed ID: 25770166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.